1. Home
  2. DXCM vs LDOS Comparison

DXCM vs LDOS Comparison

Compare DXCM & LDOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • LDOS
  • Stock Information
  • Founded
  • DXCM 1999
  • LDOS 1969
  • Country
  • DXCM United States
  • LDOS United States
  • Employees
  • DXCM N/A
  • LDOS N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • LDOS EDP Services
  • Sector
  • DXCM Health Care
  • LDOS Technology
  • Exchange
  • DXCM Nasdaq
  • LDOS Nasdaq
  • Market Cap
  • DXCM 28.0B
  • LDOS 22.4B
  • IPO Year
  • DXCM 2005
  • LDOS 2006
  • Fundamental
  • Price
  • DXCM $79.80
  • LDOS $162.66
  • Analyst Decision
  • DXCM Buy
  • LDOS Strong Buy
  • Analyst Count
  • DXCM 17
  • LDOS 14
  • Target Price
  • DXCM $101.29
  • LDOS $182.50
  • AVG Volume (30 Days)
  • DXCM 4.0M
  • LDOS 1.8M
  • Earning Date
  • DXCM 10-24-2024
  • LDOS 10-29-2024
  • Dividend Yield
  • DXCM N/A
  • LDOS 0.97%
  • EPS Growth
  • DXCM 83.21
  • LDOS 718.12
  • EPS
  • DXCM 1.67
  • LDOS 8.73
  • Revenue
  • DXCM $3,954,000,000.00
  • LDOS $16,277,000,000.00
  • Revenue This Year
  • DXCM $13.10
  • LDOS $8.43
  • Revenue Next Year
  • DXCM $14.79
  • LDOS $3.58
  • P/E Ratio
  • DXCM $48.58
  • LDOS $18.90
  • Revenue Growth
  • DXCM 16.19
  • LDOS 7.40
  • 52 Week Low
  • DXCM $62.34
  • LDOS $105.52
  • 52 Week High
  • DXCM $142.00
  • LDOS $202.90
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 67.60
  • LDOS 40.48
  • Support Level
  • DXCM $77.50
  • LDOS $162.32
  • Resistance Level
  • DXCM $82.26
  • LDOS $166.46
  • Average True Range (ATR)
  • DXCM 2.33
  • LDOS 4.62
  • MACD
  • DXCM 0.52
  • LDOS -0.85
  • Stochastic Oscillator
  • DXCM 81.49
  • LDOS 50.58

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About LDOS Leidos Holdings Inc.

Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health markets, both domestically and internationally. Company customer includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in three reportable segments; Defense Solutions, Civil, and Health. Defense Solutions provides technologically latest services, solutions, and products to a broad customer base. It generates key revenue from Defense Solutions.

Share on Social Networks: